ArticleChemMedChem2026
COMPASS: A Computational Pipeline to Identify Linkers Predicting Ubiquitinable PROTAC-Induced Ternary Complexes.
Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
PROteolysis TArgeting Chimeras (PROTACs) are bifunctional molecules designed to induce targeted protein degradation by forming a transient ternary complex between an E3 ubiquitin ligase and a protein of interest (POI), leading to the E3-mediated ubiquitination of the POI and its subsequent proteasomal degradation. Although PROTACs have emerged as highly promising therapeutic tools, rational design remains challenging due to limited structural understanding of the resulting assemblies, the dynamic nature of the ternary interface, and the critical role of the linker. Herein, we present COMPASS (COmputational Modeling of PROTAC Assembly with Structure-based Screening), a computational pipeline that allows the screening of linker libraries by assessing both ternary complex formation and ubiquitination potential. COMPASS functions as a high-sensitivity negative filter, identifying linkers that cannot form productive complexes and enabling their elimination before synthesis. Benchmarking against 20 crystallographic structures yielded <6 Å Cα-RMSD across all systems, outperforming existing methods. Retrospective validation across 8 distinct E3/POI systems (112 PROTACs) yielded 93% recall against degradation endpoints. Discriminative power is strongest when linker geometry is rate-limiting, a regime complementary to the stability and cooperativity effects that static structural modeling cannot capture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.